Home  |  Site Map  |  Glossary  | Contact
Aug. 7 QLT Announces Adoption of Advance Notice Policy
   
Aug. 5 QLT Announces Second Quarter 2014 Results
   
July 14 QLT Announces Publication in The Lancet of Phase 1b Data for QLT091001 in Leber Congenital Amaurosis due to LRAT or RPE65 Mutations
   
June 26 Auxilium Pharmaceuticals to Merge with Canadian Biotechnology Company QLT
   
 
Copyright 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking
 
Employee Login
 
'ss